Skip to Content

93 782 (Tamoxifen Citrate 20 mg)

Pill with imprint 93 782 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Teva Pharmaceuticals USA.

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, metastatic; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 782

Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate 20 mg 93 782  Front
Tamoxifen citrate 20 mg 93 782  Back
Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate 20 mg 93 782

Tamoxifen Citrate

93 782
20 mg
9.00 mm
Prescription only
Drug Class:
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00093-0782 Teva Pharmaceuticals USA, Inc.
51862-0446 Libertas Pharma
54868-4287 Physicians Total Care Inc. (repackager)
54569-5857 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.